120 related articles for article (PubMed ID: 30882496)
1. HIV-associated anorectal Epstein-Barr virus-positive mucocutaneous ulcer successfully treated with liposomal doxorubicin and rituximab.
Whooley PD; Dorer RK; Kumar AS; Aboulafia DM
AIDS; 2019 Apr; 33(5):929-930. PubMed ID: 30882496
[No Abstract] [Full Text] [Related]
2. Efficacy and Safety of Pegylated Liposomal Doxorubicin-Based Chemotherapy of AIDS-Related Kaposi's Sarcoma: A Meta-Analysis.
Liu R; Zhou J; Yang S; Zhang Z
Am J Ther; 2018; 25(6):e719-e721. PubMed ID: 29509553
[No Abstract] [Full Text] [Related]
3. Extraordinary Case: Unique Presentation of an Aggressive Epstein-Barr Virus-Positive Mucocutaneous Ulcer.
Miyashiro D; Nico MMS; Ang PL; Coelho Siqueira SA; Pereira J; Sanches JA; Lourenço SV
Am J Dermatopathol; 2022 Dec; 44(12):948-951. PubMed ID: 36332115
[TBL] [Abstract][Full Text] [Related]
4. Anorectal lymphoma without effusion associated with human herpesvirus-8 and type 1 Epstein-Barr virus in an HIV-infected patient.
Navarro JT; Ribera JM; Juncà J; Millá F
Hum Pathol; 2003 Jun; 34(6):630. PubMed ID: 12827623
[No Abstract] [Full Text] [Related]
5. EBV-positive mucocutaneous ulcer arising in rheumatoid arthritis patients treated with methotrexate: Single center series of nine cases.
Satou A; Banno S; Hanamura I; Takahashi E; Takahara T; Nobata H; Katsuno T; Takami A; Ito Y; Ueda R; Nakamura S; Tsuzuki T
Pathol Int; 2019 Jan; 69(1):21-28. PubMed ID: 30615240
[TBL] [Abstract][Full Text] [Related]
6. Clinical response to liposomal doxorubicin and rituximab in HHV-8-associated multicentric Castleman's disease in an HIV-positive patient.
Osa M; Maeda T; Misawa K; Imai K; Fujikura Y; Kawana A
J Infect Chemother; 2016 Dec; 22(12):804-807. PubMed ID: 27373909
[TBL] [Abstract][Full Text] [Related]
7. Primary classic Hodgkin lymphoma of the ileum and Epstein-Barr virus mucocutaneous ulcer of the colon: two entities compared.
Zanelli M; Mengoli MC; Valli R; Froio E; Bisagni A; Zizzo M; De Marco L; Ascani S
Virchows Arch; 2019 Jan; 474(1):117-123. PubMed ID: 30194489
[TBL] [Abstract][Full Text] [Related]
8. An aggressive case of EBV-positive mucocutaneous ulcer in the female genital area; successful response to rituximab.
Rodríguez-Lago L; Peñate Y; Marrero-Quintana MT; Andújar-Sánchez M; Rodríguez-López J
Dermatol Ther; 2022 Jul; 35(7):e15527. PubMed ID: 35441767
[No Abstract] [Full Text] [Related]
9. Multiple remissions of extracavitary primary effusion lymphoma treated with a single cycle of liposomal doxorubicin in a patient infected with HIV.
Chen J; Mehraj V; Szabo J; Routy B; Michel RP; Routy JP
Curr Oncol; 2018 Dec; 25(6):e592-e596. PubMed ID: 30607128
[TBL] [Abstract][Full Text] [Related]
10. Rectal tonsil associated with Epstein-Barr virus.
Grube-Pagola P; Canales-Kay A; Meixueiro-Daza A; Remes-Troche JM
Endoscopy; 2012; 44 Suppl 2 UCTN():E388-9. PubMed ID: 23139035
[No Abstract] [Full Text] [Related]
11. Durable remission of both multicentric Castleman's disease and Kaposi's sarcoma with valganciclovir, rituximab and liposomal doxorubicin in an HHV-8-positive, HIV-negative patient.
Murphy C; Hawkes E; Chionh F; Chong G
J Clin Pharm Ther; 2017 Feb; 42(1):111-114. PubMed ID: 27790727
[TBL] [Abstract][Full Text] [Related]
12. Epstein-Barr virus positive mucocutaneous ulcer of vulva.
Ansar S; Mahadik A; Chow C; Papapetros I; Lee CS
Pathology; 2019 Aug; 51(5):543-544. PubMed ID: 31221432
[No Abstract] [Full Text] [Related]
13. Favorable outcome of Epstein-Barr virus-associated B-cell lymphoproliferative disorder complicated by immunoglobulin G4-related disease treated with rituximab-based therapy: a case report.
Ueda K; Ikeda K; Ogawa K; Sukegawa M; Sano T; Kimura S; Suzuki O; Hashimoto Y; Takeishi Y
J Med Case Rep; 2016 Aug; 10(1):236. PubMed ID: 27557810
[TBL] [Abstract][Full Text] [Related]
14. Pegylated liposomal doxorubicin consolidation therapy.
Hamm W
Oncologist; 2006; 11(7):855; author reply 855-6. PubMed ID: 16880247
[No Abstract] [Full Text] [Related]
15. Triple secondary neoplasms: penis, lip and oral cavity in an AIDS patient treated with pegylated liposomal doxorubicin for cutaneous Kaposi's sarcoma.
Volkow P; Lizano M; Carrillo-García A; Pérez-Montiel D; Garciadiego P
AIDS; 2014 Sep; 28(15):2327-9. PubMed ID: 25313589
[No Abstract] [Full Text] [Related]
16. Epstein-Barr virus-positive diffuse large B-cell lymphoma of the elderly treated with rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone: report of two cases from South America.
Beltran BE; Castillo JJ; Salas R; Quiñones P; Morales D; Cotrina E; Miranda RN; Sotomayor EM
Leuk Lymphoma; 2011 Jan; 52(1):153-6. PubMed ID: 21219127
[No Abstract] [Full Text] [Related]
17. A Kidney Transplant Recipient With a Perforated Cheek: Oral Epstein-Barr Virus-Positive Mucocutaneous Ulcer Complicated With an Opportunistic Bacterial Infection.
Eleftheriadis T; Rountas C; Golfinopoulos S; Liakopoulos V; Stefanidis I
Exp Clin Transplant; 2021 Aug; 19(8):868-870. PubMed ID: 34085910
[TBL] [Abstract][Full Text] [Related]
18. AIDS-related Kaposi's sarcoma with chylothorax and pericardial involvement satisfactorily treated with liposomal doxorubicin.
Maradona JA; Carton JA; Asensi V; Rodríguez-Guardado A
AIDS; 2002 Mar; 16(5):806. PubMed ID: 11964546
[No Abstract] [Full Text] [Related]
19. Disseminated classic Kaposi's sarcoma. Two cases with excellent response to pegylated liposomal doxorubicin.
Castiñeiras I; Almagro M; Rodríguez-Lozano J; Fernández-Jorge B; Paradela S; Pozo JD; Fonseca E
J Dermatolog Treat; 2006; 17(6):377-80. PubMed ID: 17853313
[TBL] [Abstract][Full Text] [Related]
20. Pegylated liposomal doxorubicin: a guide to its use in various malignancies.
Lyseng-Williamson KA; Duggan ST; Keating GM
BioDrugs; 2013 Oct; 27(5):533-40. PubMed ID: 24018470
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
